Stay updated on Dapirolizumab Pegol Safety in Lupus Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.

Latest updates to the Dapirolizumab Pegol Safety in Lupus Clinical Trial page
- Check4 days agoChange DetectedA new version entry appears in the study history on 2026-07-10, introducing updated Study Status and Contacts/Locations. The prior 2026-06-26 entry was removed.SummaryDifference0.2%

- Check11 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3 at the bottom of the page, reflecting a new site release. This update does not affect study data, records, or navigation on the page.SummaryDifference0.0%

- Check18 days agoChange DetectedThe history shows a new 2026-06-26 entry adding Contacts/Locations and Study Status with Revision: v3.6.2, updating the record from the previous v3.6.0 entry.SummaryDifference0.2%

- Check32 days agoChange DetectedA new revision entry (v3.6.0, dated 2026-06-12) introduces Contacts/Locations and Study Status sections to the study history page, replacing the previous revision (v3.5.5) from 2026-05-29.SummaryDifference0.3%

- Check40 days agoChange DetectedA new version entry dated 2026-05-29 adds updated Study Status and Contacts/Locations to the record, updating the revision to v3.5.5. The previous revision (2026-05-15, v3.5.4) is removed from the history.SummaryDifference0.2%

- Check54 days agoChange DetectedA new version entry dated 2026-05-15 with added Contacts/Locations and Study Status sections was added to the history, and the 2026-05-01 entry was removed.SummaryDifference0.2%

Stay in the know with updates to Dapirolizumab Pegol Safety in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.